Replies to post #127 on Evaxion Biotech AS (EVAX)

[Bourbon_on_my_cornflakes]

If EVAX data good, that is another $600m vaccine, actually more since it will have passed P3. Let say $1 billion.
Then 'you realize that the EVAX AI platform can keep developing more of them.
Got to be at least 5 $600m-$1 billion market disease targets out there
So a value of $3-6 billion in a buyout eventually achievable.
yes, that is $500-$1000 a share on 6 million shares.